Associations of CTCF and FOXA1 with androgen and IGF pathways in men with localized prostate cancer

被引:1
|
作者
Barker, Rachel [1 ]
Biernacka, Kalina [1 ]
Kingshott, Georgina [1 ]
Sewell, Alex [2 ]
Gwiti, Paida [2 ,3 ]
Martin, Richard M. [4 ,5 ,6 ]
Lane, J. Athene [7 ]
McGeagh, Lucy [8 ]
Koupparis, Anthony [9 ]
Rowe, Edward [9 ]
Oxley, Jon [2 ]
Perks, Claire M. [1 ]
Holly, Jeff M. P. [1 ]
机构
[1] Southmead Hosp, Bristol Med Sch, IGF & Metab Endocrinol Grp, Translat Hlth Sci, Learning & Res Bldg, Bristol BS10 5NB, England
[2] Southmead Hosp, Dept Cellular Pathol, North Bristol NHS Trust, Bristol BS10 5NB, England
[3] North West Anglia NHS Fdn Trust, Dept Pathol, Peterborough PE3 2PS, England
[4] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, 39 Whatley Rd,Canynge Hall, Bristol BS8 2PS, England
[5] Univ Hosp Bristol, Biomed Res Ctr, Natl Inst Hlth Res, Lower Maudlin St, Bristol BS1 2LY, England
[6] Weston NHS Fdn Trust & Univ Bristol, Univ Hosp Bristol Educ Ctr, Dent Hosp, Biomed Res Unit Off, Lower Maudlin St, Bristol BS1 2LY, England
[7] Univ Bristol, Bristol Trials Ctr, Bristol Med Sch, Populat Hlth Sci, 39 Whatley Rd,Canynge Hall, Bristol BS8 2PS, England
[8] Oxford Brookes Univ, Oxford Inst Nursing, Fac Hlth & Life Sci, Support Canc Care Res Grp,Midwifery & Allied Hlth, Jack Straws Lane, Oxford OX3 0FL, England
[9] Southmead Hosp, Bristol Urol Inst, Dept Urol, Bristol BS10 5NB, England
基金
英国医学研究理事会;
关键词
IGF; CTCF; FOXA1; Prostate cancer; Androgen signaling; FORKHEAD BOX A1; RECEPTOR-BINDING; RISK VARIANTS; EXPRESSION; REVEALS; BREAST; MASTER; H19;
D O I
10.1016/j.ghir.2023.101533
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: To examine associations between the transcription factors CCCTC-binding factor (CTCF) and forkhead box protein A1 (FOXA1) and the androgen receptor (AR) and their association with components of the insulin-like growth factor (IGF)-pathway in a cohort of men with localized prostate cancer.Methods: Using prostate tissue samples collected during the Prostate cancer: Evidence of Exercise and Nutrition Trial (PrEvENT) trial (N = 70 to 92, depending on section availability), we assessed the abundance of CTCF, FOXA1, AR, IGFIR, p-mTOR, PTEN and IGFBP-2 proteins using a modified version of the Allred scoring system. Validation studies were performed using large, publicly available datasets (TCGA) (N = 489).Results: We identified a strong correlation between CTCF and AR staining with benign prostate tissue. CTCF also strongly associated with the IGF-IR, with PTEN and with phospho-mTOR. FOXA1 was also correlated with staining for the IGF-IR, with IGFBP-2 and with staining for activated phosphor-mTOR. The staining for the IGF-IR was strongly correlated with the AR.Conclusion: Our findings emphasise the close and complex links between the endocrine controls, well known to play an important role in prostate cancer, and the transcription factors implicated by the recent genetic evidence.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] FOXA1 in prostate cancer
    Dong, Hui-Yu
    Ding, Lei
    Zhou, Tian-Ren
    Yan, Tao
    Li, Jie
    Liang, Chao
    ASIAN JOURNAL OF ANDROLOGY, 2023, 25 (03) : 287 - 295
  • [2] Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer
    Zhao, Yu
    Tindall, Donald J.
    Huang, Haojie
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2014, 10 (06): : 614 - 619
  • [3] Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer
    Yang, Yeqing Angela
    Yu, Jindan
    GENES & DISEASES, 2015, 2 (02) : 144 - 151
  • [4] FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer
    Jones, Dominic
    Wade, Mark
    Nakjang, Sirintra
    Chaytor, Lewis
    Grey, James
    Robson, Craig N.
    Gaughan, Luke
    ONCOTARGET, 2015, 6 (30) : 29782 - 29794
  • [5] FOXA1 regulates alternative splicing in prostate cancer
    Del Giudice, Marco
    Foster, John G.
    Peirone, Serena
    Rissone, Alberto
    Caizzi, Livia
    Gaudino, Federica
    Parlato, Caterina
    Anselmi, Francesca
    Arkell, Rebecca
    Guarrera, Simonetta
    Oliviero, Salvatore
    Basso, Giuseppe
    Rajan, Prabhakar
    Cereda, Matteo
    CELL REPORTS, 2022, 40 (13):
  • [6] FOXA1 inhibits prostate cancer neuroendocrine differentiation
    Kim, J.
    Jin, H.
    Zhao, J. C.
    Yang, Y. A.
    Li, Y.
    Yang, X.
    Dong, X.
    Yu, J.
    ONCOGENE, 2017, 36 (28) : 4072 - 4080
  • [7] FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
    Sahu, Biswajyoti
    Laakso, Marko
    Pihlajamaa, Paivi
    Ovaska, Kristian
    Sinielnikov, Ievgenii
    Hautaniemi, Sampsa
    Janne, Olli A.
    CANCER RESEARCH, 2013, 73 (05) : 1570 - 1580
  • [8] Frequent mutation of the FOXA1 untranslated region in prostate cancer
    Annala, Matti
    Taavitsainen, Sinja
    Vandekerkhove, Gillian
    Bacon, Jack V. W.
    Beja, Kevin
    Chi, Kim N.
    Nykter, Matti
    Wyatt, Alexander W.
    COMMUNICATIONS BIOLOGY, 2018, 1
  • [9] Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
    Robinson, Jessica L. L.
    MacArthur, Stewart
    Ross-Innes, Caryn S.
    Tilley, Wayne D.
    Neal, David E.
    Mills, Ian G.
    Carroll, Jason S.
    EMBO JOURNAL, 2011, 30 (15) : 3019 - 3027
  • [10] FOXA1 regulates ribosomal RNA transcription in prostate cancer
    Jia, Tianwei
    Liu, Chenxu
    Guo, Ping
    Xu, Yaning
    Wang, Wenzheng
    Liu, Xiaoyu
    Wang, Song
    Zhang, Xianglin
    Guo, Haiyang
    PROSTATE, 2024, 84 (10) : 967 - 976